
Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial
Alberú, Josefina, Pascoe, Michael D., Campistol, Josep M., Schena, Francesco P., Rial, Maria del Carmen, Polinsky, Martin, Neylan, John F., Korth-Bradley, Joan, Goldberg-Alberts, Robert, Maller, EricVolume:
92
Langue:
english
Journal:
Transplantation
DOI:
10.1097/tp.0b013e3182247ae2
Date:
August, 2011
Fichier:
PDF, 386 KB
english, 2011